South American Thoracic Stent-Graft Study

A Pilot Trial to Evaluate the Performance of the TriVascular Thoracic Stent Graft System

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01082172

Enrollment

Registered

2010-03-08

Start date

2009-11-30

Completion date

2011-05-31

Last updated

2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Aortic Aneurysm

Keywords

thoracic, aortic, aneurysm, TAA

Brief summary

A prospective, non-randomized multi-center clinical evaluation of the performance of the TriVascular Thoracic Stent Graft System when used in the treatment of subjects with thoracic aortic aneurysms (TAA).

Interventions

DEVICEImplant Thoracic Stent Graft

Endovascular implant of Thoracic Aortic Aneurysm Stent Graft

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* The TriVascular Thoracic Stent Graft System is indicated in subjects diagnosed with an aneurysm in the descending thoracic aorta having vascular morphology suitable for endovascular repair, including: * Adequate iliac/femoral access compatible with the required delivery systems, * Non-aneurysmal aortic segments proximal and distal to the aneurysm.

Design outcomes

Primary

Measure	Time frame
Absence of device-related serious adverse events within 30-days of endovascular procedure	30-Days

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026